Business Wire

Soundtrap for Storytellers, New Podcast Creation Tool, Launches Globally

Del

Soundtrap, a Spotify company, today announced Soundtrap for Storytellers, a cloud-based one-stop shop for high-quality collaborative podcast creation that provides podcasters with a powerful, efficient and user-friendly recording and production process.

Now available globally, Soundtrap for Storytellers is a comprehensive podcast creation solution that offers all of the following features in the same service: recording; remote multi-track interviewing with video chat; smart transcribing and editing of the spoken-word audio file as a text document; full audio production capabilities, the publishing of its transcript to optimize SEO, and the publishing of the podcast to Spotify.

“Soundtrap was created to redefine collaborative music making, and now we’re bringing that same expertise to podcast creation with Soundtrap for Storytellers. The platform itself was built around solving some of the biggest pain points for podcasters - editing, transcribing, remote interviewing and adding sound effects - and providing one, streamlined platform that contains every part of the podcast creation process,” said Per Emanuelsson, Co-Founder, Soundtrap.

“The Soundtrap team has done a fantastic job with this new product. Part of Spotify’s mission is to grow the number of creators able to build podcasts worldwide. Soundtrap for Storytellers gives podcast creators incredible editing capabilities, collaboration in real-time, and the ability to publish their podcast to Spotify,” said Charlie Hellman, Head of Creator Marketplace, Spotify.

Equipped with a wide range of intuitive features, Soundtrap for Storytellers allows podcasters to focus on the art of storytelling by significantly reducing the time and investment typically needed to make podcasts sound professional. The full suite of services can be accessed via desktop, and a select set of recording and editing features is available on iOS and Android. Tools available include:

  • Interactive Transcripts/Editing Studio: Soundtrap for Storytellers saves hours of time by enabling users to transcribe and edit the spoken-word audio file as you would in a text document, eliminating the need to listen to the podcast over and over again. For now, transcription is only available in English.
  • Collaborate and Remotely Interview Guests: Soundtrap for Storytellers enables podcasters to seamlessly collaborate with others from anywhere around the world. The platform is cloud-based and allows multiple people to talk, record (on separate tracks) and work on the same podcast by sending a link to join the session remotely.
  • Increase Discoverability: Publish your podcast transcript to increase SEO, drive traffic to your podcast, and gain new fans.
  • Sound Effects: Create your own jingle and complete your production with sound design using Soundtrap’s built-in instruments and loops, and access an enormous sound library without having to leave the studio.

Soundtrap for Storytellers is available today, May 14, 2019, at Soundtrap.com/Storytellers . Pricing begins at $14.99/month and an annual plan is available starting at $11.99/month.

ABOUT SOUNDTRAP

Soundtrap is the first cloud-based audio recording platform to work across all operating systems, enabling users to co-create music and podcasts anywhere in the world. The company is headquartered in Stockholm, Sweden. Soundtrap provides an easy-to-use music and audio creation platform for all levels of musical interest and abilities and is being used by the K-12 through higher-education markets. On December 2017, Soundtrap was acquired by Spotify. For more information, visit https://www.soundtrap.com/.

Contact information

Ida Ståhlnacke
idas@spotify.com
+46 72 249 98 11
OR
Danielle Dickinson
Danielle.Dickinson@hkstrategies.com
(713) 751-1906

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 20:00:00 CESTPressemelding

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol